BNTX Projected Dividend Yield
ADS/BioNTech SE ( NASDAQ : BNTX )BioNTech SE is a Germany-based clinical-stage biotechnology company. Co. focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. Co. is providing technologies including mRNA-based therapies, cell therapies, small molecules and antibodies, which can be utilized for specific purposes or can be even combined with each other in a synergistic manner. It also develops a broad product pipeline using different scientific approaches and technology platforms, including individualized mRNA-based product candidates, chimeric antigen receptor T-cells, checkpoint immunomodulators, targeted cancer antibodies and small molecules. 12 YEAR PERFORMANCE RESULTS |
BNTX Dividend History Detail BNTX Dividend News BNTX Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
2022 |
N/A |
Jun 02, 2022 |
Jun 03, 2022 |
Jun 17, 2022 |
1.5498 |
2022 Total: |
1.5498 |